How Recent Data Impacts Pancreatic Cancer Management

Integrity CE

M. Pishvaian

Year in Review: Colorectal Cancer

Moffitt Cancer Center

R. Kim, T. Biachi

Recent Updates in Upper Gl Cancers

Integrity CE

S. Mukherjee

The Importance of 1L Biomarkers in CRC

Nicholas DeVito

ASCO® 2024 Insights: "The GIANT Trial (EA2186) - Gem & nab-Paclitaxe…

2024 ASCO® Annual Meeting Insights Hub

E. Dotan

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

ESMO 2024 Summary: Late-Line Therapy in mCRC - How to Choose

2024 ESMO Annual Meeting Insights Hub

H. Hochster

ASCO® 2023 Summary: "GI Key Studies Including PROSPECT, HERIZON-BTC-…

Insights from 2023 ASCO® Annual Meeting

R. Kim, R. Mehta

Debates in Neoadjuvant Therapy in Resectable Pancreatic Cancer: Why …

Integrity CE

L. Zheng

ASCO® 2024 Insights: "5-Year Results From the Randomized DYNAMIC Tri…

2024 ASCO® Annual Meeting Insights Hub

J. Tie

ASCO® 2024 Summary: "Expert Panel Discussion on Upper-GI Cancers Inc…

2024 ASCO® Annual Meeting Insights Hub

N. Uboha, A. Turk, K. Spencer, M. Cecchini

ESMO 2024 Summary: Neoadjuvant Colon Cancer Treatment - Recent Clini…

2024 ESMO Annual Meeting Insights Hub

J. Taieb

ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates

ASCO GI 2023 Conference Coverage

N. Uboha, A. Turk, K. Spencer, M. Cecchini

GI Cancers: Hot Topics in 2024

Yale Cancer Center

J. Lacy

ASCO® 2024 Summary: "CRC Key Studies Including TRANSMET, CheckMate 8…

2024 ASCO® Annual Meeting Insights Hub

R. Kim, T. Biachi

ESMO 2024 Summary: Updates in Pancreatic Cancer and Impacts on Pract…

2024 ESMO Annual Meeting Insights Hub

H. Babiker

ASCO® 2024 Precision Medicine Highlights: LAURA and CROWN Trials (NS…

2024 ASCO® Annual Meeting Insights Hub

V. Subbiah

NORPACT-1 Trial Updates: Neoadjuvant FOLFIRINOX vs. Upfront Surgery …

Yale Cancer Center

J. Lacy

Treating KRAS-Mutated mCRC

Ibrahim Sahin

Year in Review: Upper GI Cancers

Moffitt Cancer Center

R. Kim, R. Mehta